arrow
A

Alexandra Gomez-Arteaga

Cornell University
H指数:9
被引数:292
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Epigenetic Priming with Azacitidine Prior to Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies

在骨髓恶性肿瘤患者异基因造血干细胞移植前采用阿扎胞苷进行表观遗传预激

2026-08-150
PRE
SOHO State of the Art Updates and Next Questions | Best of Stem Cell Transplant: Recent Advances in Allogeneic Hematopoietic Cell Transplantation

SOHO 技术现状更新与后续问题 | 造血干细胞移植最佳实践:同种异基因造血细胞移植的最新进展

2026-08-010
PRE
Racial and ethnic disparities in brain-to-vein time among patients receiving CD19 CAR-T cell therapy for relapsed/refractory DLBCL

接受CD19 CAR-T细胞治疗的复发/难治性DLBCL患者中脑静脉时间的人种和民族差异

2026-07-220
PRE
Real-world assessment of prophylactic anakinra on neurotoxicity and cytokine release syndrome after CD19 CAR T-cell therapy in R/R B-cell lymphoma: An inverse probability of treatment weighting analysis

R/R B细胞淋巴瘤患者接受CD19 CAR T细胞疗法后,预防性使用阿那白滞素对神经毒性和细胞因子释放综合征影响的真实世界评估:一项逆概率治疗加权分析

2026-06-170
PRE
Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial

Orca-T与异基因造血干细胞移植(PRECISION-T):一项多中心、随机III期试验

Blood
IF23.1
2025-12-160
OAAI
Beyond favorable: early molecular response and outcomes in pediatric RUNX1::RUNX1T1 AML
2025-10-010
PRE
Understanding Diversity: An ASTCT-NMDP ACCESS Initiative Survey of the Hematopoietic Cell Transplant and Cellular Therapy Workforce in the United States

理解多样性:ASTCT-NMDP ACCESS计划对美国造血细胞移植与细胞治疗从业人员的一项调查

2025-09-270
PRE
Physician Advocacy for Hematopoietic Cell Transplantation and Cell Therapy: Overcoming Challenges to Reduce Disparities and Improve Outcomes for Patients

医师对造血细胞移植和细胞治疗的倡导:克服挑战以减少患者差异并改善预后

2025-09-260
PRE
Availability of suitable domestic cord blood grafts for adult allograft recipients with hematologic malignancies

适合成人血液系统恶性肿瘤异基因移植受者的合适自体脐带血移植物的可用性

2025-09-170
PRE
Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop
2024-12-012
PRE
Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+selected Cells [Haplo-Cord] Versus Matched Donors)

骨髓纤维化的移植结果: 供体类型的影响 (由CD34选择的细胞 [haplo-cord] 支持的脐带血移植物与匹配的供体)

2024-11-010
PRE
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome

中重度急性呼吸窘迫综合征不变自然杀伤T细胞治疗的1/2期临床试验

2024-02-066
OAAI
Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative Workshop
2023-12-015
OAAI
Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation

异基因造血干细胞移植前胸部CT筛查

2023-05-014
OAAI
Measurable residual disease after CAR T-cell therapy

CAR T细胞治疗后可测量的残留疾病

2023-01-012
PRE
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation
2022-09-0112
OAAI
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML
2022-02-0111
OAAI
Untitled Reply
2021-12-031
OA
Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML
2021-08-3014
OAAI
Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients
2021-05-0636
OA